This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goldmuntz, E. Articles by Benson, D. W. Search for Related Content PubMed PubMed Citation Articles by Goldmuntz, E. Articles by Benson, D. W. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM Protein UniGene Related Collections Clinical genetics Pediatric and congenital heart disease, including cardiovascular surgery Genetics of cardiovascular disease

(Circulation. 2001;104:2565.)
© 2001 American Heart Association, Inc.

Clinical Investigation and Reports

NKX2.5 Mutations in Patients With Tetralogy of Fallot

Elizabeth Goldmuntz, MD; Elizabeth Geiger, MS; D. Woodrow Benson, MD PhD

From the Division of Cardiology, The Children’s Hospital of Philadelphia (E. Goldmuntz, E. Geiger), Philadelphia, Pa, and Medical University of South Carolina (D.W.B.), Charleston, SC. Dr Benson currently is affiliated with the Children’s Hospital Medical Center, Cincinnati, Ohio.

Correspondence to Elizabeth Goldmuntz, MD, The Children’s Hospital of Philadelphia, Abramsom Research Center 702A, 3516 Civic Center Blvd, Philadelphia, PA 19104-4318. E-mail goldmuntz{at}email.chop.edu

Background Recent reports have implicated mutations in the transcription factor NKX2.5 as a cause of tetralogy of Fallot (TOF). To estimate the frequency of NKX2.5 mutations in TOF patients and to further investigate the genotype-phenotype correlation of NKX2.5 mutations, we genotyped 114 TOF patients.

Methods and Results Patients were recruited prospectively (November 1992 through June 1999) and tested for a 22q11 deletion; those with 22q11 deletion or recognized chromosomal alteration were excluded from the present study. Patients were screened for NKX2.5 alterations by conformation-sensitive gel electrophoresis and sequencing of fragments with aberrant mobility. Four heterozygous mutations were identified in 6 unrelated patients with cases of TOF, including 3 with pulmonary atresia and 5 with right aortic arch; none had ECG evidence of PR interval prolongation. Three of 4 mutations (Glu21Gln, Arg216Cys, and Ala219Val) altered highly conserved amino acids, of which 2 mapped in the conserved NK2 domain. The fourth mutation (Arg25Cys) was identified in 3 unrelated probands in the present study and has been previously reported. No homeodomain mutations were identified.

Conclusions NKX2.5 mutations are the first gene defects identified in nonsyndromic TOF patients. NKX2.5 mutation is present in 4% of TOF patients. Mutations identified in the present study mapped outside of the homeodomain, were not associated with atrioventricular conduction disturbances, and were not fully penetrant, in contrast to mutations previously reported that impair homeodomain function.

Key Words: genetics • heart defects, congenital • tetralogy of Fallot

This article has been cited by other articles:

				G. Michielon, B. Marino, G. Oricchio, M. C. Digilio, F. Iorio, S. Filippelli, S. Placidi, and R. M. Di Donato Impact of DEL22q11, trisomy 21, and other genetic syndromes on surgical outcome of conotruncal heart defects J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 565 - 570. [Abstract] [Full Text] [PDF]

				A. Nakano, H. Nakano, and K.R. Chien Multipotent Islet-1 Cardiovascular Progenitors in Development and Disease Cold Spring Harb Symp Quant Biol, February 9, 2009; (2009) sqb.2008.73.055v1. [Abstract] [PDF]

				J M Draus Jr, M A Hauck, M Goetsch, E H Austin III, A Tomita-Mitchell, and M E Mitchell Investigation of somatic NKX2-5 mutations in congenital heart disease J. Med. Genet., February 1, 2009; 46(2): 115 - 122. [Abstract] [Full Text] [PDF]

				K. L. McBride, M. F. Riley, G. A. Zender, S. M. Fitzgerald-Butt, J. A. Towbin, J. W. Belmont, and S. E. Cole NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling Hum. Mol. Genet., September 15, 2008; 17(18): 2886 - 2893. [Abstract] [Full Text] [PDF]

				S. T. MacDonald, S. D. Bamforth, C.-M. Chen, C. R. Farthing, A. Franklyn, C. Broadbent, J. E. Schneider, Y. Saga, M. Lewandoski, and S. Bhattacharya Epiblastic Cited2 deficiency results in cardiac phenotypic heterogeneity and provides a mechanism for haploinsufficiency Cardiovasc Res, August 1, 2008; 79(3): 448 - 457. [Abstract] [Full Text] [PDF]

				E. Bedard, D. F. Shore, and M. A. Gatzoulis Adult congenital heart disease: a 2008 overview Br. Med. Bull., March 1, 2008; 85(1): 151 - 180. [Abstract] [Full Text] [PDF]

				K.-L. Laugwitz, A. Moretti, L. Caron, A. Nakano, and K. R. Chien Islet1 cardiovascular progenitors: a single source for heart lineages? Development, January 15, 2008; 135(2): 193 - 205. [Abstract] [Full Text] [PDF]

				A Tomita-Mitchell, C L Maslen, C D Morris, V Garg, and E Goldmuntz GATA4 sequence variants in patients with congenital heart disease J. Med. Genet., December 1, 2007; 44(12): 779 - 783. [Abstract] [Full Text] [PDF]

				M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF]

				T. M. Bashore Adult Congenital Heart Disease: Right Ventricular Outflow Tract Lesions Circulation, April 10, 2007; 115(14): 1933 - 1947. [Full Text] [PDF]

				R. Majumdar, M. Yagubyan, G. Sarkar, M. E. Bolander, and T. M. Sundt III Bicuspid aortic valve and ascending aortic aneurysm are not associated with germline or somatic homeobox NKX2-5 gene polymorphism in 19 patients J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1301 - 1305. [Abstract] [Full Text] [PDF]

				E. P. Kirk, C. Hyun, P. C. Thomson, D. Lai, M. L. Castro, C. Biben, M. F. Buckley, I. C.A. Martin, C. Moran, and R. P. Harvey Quantitative Trait Loci Modifying Cardiac Atrial Septal Morphology and Risk of Patent Foramen Ovale in the Mouse Circ. Res., March 17, 2006; 98(5): 651 - 658. [Abstract] [Full Text] [PDF]

				G. Michielon, B. Marino, R. Formigari, G. Gargiulo, F. Picchio, M. C. Digilio, S. Anaclerio, G. Oricchio, S. P. Sanders, and R. M. Di Donato Genetic Syndromes and Outcome After Surgical Correction of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2006; 81(3): 968 - 975. [Abstract] [Full Text] [PDF]

				J. A. Epstein and M. S. Parmacek Recent Advances in Cardiac Development With Therapeutic Implications for Adult Cardiovascular Disease Circulation, July 26, 2005; 112(4): 592 - 597. [Full Text] [PDF]

				A. Inga, S. M. Reamon-Buettner, J. Borlak, and M. A. Resnick Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system Hum. Mol. Genet., July 15, 2005; 14(14): 1965 - 1975. [Abstract] [Full Text] [PDF]

				D Lambrechts, K Devriendt, D A Driscoll, E Goldmuntz, M Gewillig, R Vlietinck, D Collen, and P Carmeliet Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study J. Med. Genet., June 1, 2005; 42(6): 519 - 522. [Full Text] [PDF]

				J. K. Takeuchi, M. Mileikovskaia, K. Koshiba-Takeuchi, A. B. Heidt, A. D. Mori, E. P. Arruda, M. Gertsenstein, R. Georges, L. Davidson, R. Mo, et al. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development Development, May 15, 2005; 132(10): 2463 - 2474. [Abstract] [Full Text] [PDF]

				L. B. Pauliks, K.-C. Chan, A. Lorts, E. R. Elias, R. O. Cayre, and L. M. Valdes-Cruz Shprintzen-Goldberg Syndrome With Tetralogy of Fallot and Subvalvar Aortic Stenosis J. Ultrasound Med., May 1, 2005; 24(5): 703 - 706. [Full Text] [PDF]

				A Sarkozy, E Conti, C Neri, R D'Agostino, M C Digilio, G Esposito, A Toscano, B Marino, A Pizzuti, and B Dallapiccola Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors J. Med. Genet., February 1, 2005; 42(2): e16 - e16. [Full Text] [PDF]

				D. D. Brown, S. N. Martz, O. Binder, S. C. Goetz, B. M. J. Price, J. C. Smith, and F. L. Conlon Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis Development, February 1, 2005; 132(3): 553 - 563. [Abstract] [Full Text] [PDF]

				C. Mittmann Molecular basis of AV block and cardiac malformations Cardiovasc Res, October 1, 2004; 64(1): 1 - 2. [Full Text] [PDF]

				H. Kasahara and D. W. Benson Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies Cardiovasc Res, October 1, 2004; 64(1): 40 - 51. [Abstract] [Full Text] [PDF]

				S M Reamon-Buettner and J Borlak Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease J. Med. Genet., September 1, 2004; 41(9): 684 - 690. [Abstract] [Full Text] [PDF]

				A Okubo, O Miyoshi, K Baba, M Takagi, K Tsukamoto, A Kinoshita, K Yoshiura, T Kishino, T Ohta, N Niikawa, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family J. Med. Genet., July 1, 2004; 41(7): e97 - e97. [Full Text] [PDF]

				S. M. Reamon-Buettner, H. Hecker, K. Spanel-Borowski, S. Craatz, E. Kuenzel, and J. Borlak Novel NKX2-5 Mutations in Diseased Heart Tissues of Patients with Cardiac Malformations Am. J. Pathol., June 1, 2004; 164(6): 2117 - 2125. [Abstract] [Full Text] [PDF]

				D. B. McElhinney, E. Geiger, J. Blinder, D. Woodrow Benson, and E. Goldmuntz NKX2.5 mutations in patients with congenital heart disease J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1650 - 1655. [Abstract] [Full Text] [PDF]

				H. K. Gill, M. Splitt, G. K. Sharland, and J. M. Simpson Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography J. Am. Coll. Cardiol., September 3, 2003; 42(5): 923 - 929. [Abstract] [Full Text] [PDF]

				M. Ganga, H. M. Espinoza, C. J. Cox, L. Morton, T. A. Hjalt, Y. Lee, and B. A. Amendt PITX2 Isoform-specific Regulation of Atrial Natriuretic Factor Expression: SYNERGISM AND REPRESSION WITH Nkx2.5 J. Biol. Chem., June 13, 2003; 278(25): 22437 - 22445. [Abstract] [Full Text] [PDF]

				D. A. Elliott, E. P. Kirk, T. Yeoh, S. Chandar, F. McKenzie, P. Taylor, P. Grossfeld, D. Fatkin, O. Jones, P. Hayes, et al. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: Associations with atrial septal defect and hypoplastic left heart syndrome J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2072 - 2076. [Abstract] [Full Text] [PDF]

				P A Jezewski, A R Vieira, C Nishimura, B Ludwig, M Johnson, S E O'Brien, S Daack-Hirsch, R E Schultz, A Weber, B Nepomucena, et al. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate J. Med. Genet., June 1, 2003; 40(6): 399 - 407. [Abstract] [Full Text] [PDF]

				J. A. Epstein, D. J. Rader, and M. S. Parmacek Perspective: Cardiovascular Disease in the Postgenomic Era--Lessons Learned and Challenges Ahead Endocrinology, June 1, 2002; 143(6): 2045 - 2050. [Full Text] [PDF]

				B. G. Bruneau Transcriptional Regulation of Vertebrate Cardiac Morphogenesis Circ. Res., March 22, 2002; 90(5): 509 - 519. [Abstract] [Full Text] [PDF]

				R.P. HARVEY, D. LAI, D. ELLIOTT, C. BIBEN, M. SOLLOWAY, O. PRALL, F. STENNARD, A. SCHINDELER, N. GROVES, L. LAVULO, et al. Homeodomain Factor Nkx2-5 in Heart Development and Disease Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 107 - 114. [Abstract] [PDF]